Current Issue
Volume 54, Number 2 February 2025
Research explores the latest advanced role, mechanism, treatment and safety of hydroxychloroquine (HCQ) in rheumatic diseases during pregnancy and application prospects of HCQ in preeclampsia.
Featured
iPARTY study: Increasing pre-exposure prophylaxis access and reach via telehealth for young men who have sex with men in Singapore 2022–2023
The efficacy and safety of radiofrequency ablation in papillary thyroid carcinoma: A systematic review and meta-analysis
Premature ovarian insufficiency: When ovaries retire early
Health-related quality of life in Singapore: Population norms for the EQ-5D-5L and EORTC QLQ-C30
Mechanisms and roles of hydroxychloroquine in pregnancy in rheumatic diseases
Prevalence of complexity in primary care and its associated factors: A Singapore experience
Adolescent self-harm and suicide attempts: An analysis of emergency department presentations in Singapore
Development and validation of the sarcopenia composite index: A comprehensive approach for assessing sarcopenia in the ageing population
Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience
Epidemiology of paediatric intensive care unit admissions, deaths and organ donation candidacy: A single-centre audit
Radiologic placement of totally implantable venous access devices: Outcomes and complications from a large oncology cohort
Consensus guidelines for the management of treatment-naïve chronic lymphocytic leukaemia in Singapore (2024)
Call For Papers
The Annals is the official journal of the Academy of Medicine, Singapore. Established in 1972, Annals is the leading medical journal in Singapore which aims to publish novel findings from clinical research as well as medical practices that can benefit the medical community.
Published monthly online, the Annals is indexed in PubMed/MEDLINE, Science Citation Index Expanded, Current Contents/Clinical Medicine and SCOPUS. We are ranked in the first quartile in the competitive category of Medicine (General and Internal) (Clarivate 2023).
The rapidly ageing population and enlarging burden of chronic diseases require a proportionate emphasis on health promotion and disease prevention. A health system that is more data-driven and patient-centric, which leverages the innovative use of technology and digital solutions, will be areas warranting research attention and coverage. The Annals invites submission of manuscripts that advance the scientific basis of clinical knowledge, and the practice of medicine in Singapore and internationally. We welcome submissions that address challenges in the management of chronic diseases (e.g. cancer, cardiovascular diseases, ageing, diabetes mellitus and neurological diseases), and use of technology and digital medicine to improve patient care.
Papers of sufficient merits will be published. Authors will also be notified if their manuscripts are deemed not suitable for publication.
